Regulations.gov document
Annexure I - Copy of Orange Book data, listing the discontinuation of K-TAB (Potassium…
Supporting & Related Material · FDA-2023-P-2339 · posted Jun 8, 2023
Key facts
| Document ID | FDA-2023-P-2339-0003 |
|---|---|
| Title | Annexure I - Copy of Orange Book data, listing the discontinuation of K-TAB (Potassium Chloride) Extended Release Tablets 10 mEq and 20 mEq, NDA No. 018279 RE Citizen Petition from Granules India Limited |
| Document type | Supporting & Related Material |
| Subtype | Background Material |
| Agency | FDA |
| Docket | FDA-2023-P-2339 |
| Posted | Jun 8, 2023 |
At a glance
- None Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: